Supporting scientific research
Henk Broeders | Chairman Member RvC PGGM NV and Alexander Monro Breast cancer hospital. Senior Partner McKinsey & Company 1998-2018. |
Trienke Stellema-Langius | Treasurer Board member and supervisor in the Health Care industry. |
Bart Kiemeneij | General board member Professor of Cancer Epidemiology / Head of Health Evidence Department, Radboudumc |
Joost Weyler | General board member Professor Epidemiology, department of Epidemiology and Social Medicine at University of Antwerp. |
Judith van Gasteren | Director Legal Director Baker McKenzie 2004-2018 |
The SAB is formally appointed by the board. SAB-members are scientists and experts from universities, other research institutes or businesses in the Netherlands and abroad. These experienced researchers and/or people are skilled reviewers of research. A geographic diversity of disciplines and institutes is sought after in the selection of SAB-members.
The SAB judges research propositions and advises the board. The current SAB consists of:
|
![]() Medical Oncologist AMC |
|
![]() Professor of Clinical Data Sciences Maastro |
![]() Head Pathology Department UMC Utrecht |
|
![]() Professor of Data Science Radboud UMC |
![]() Head of Radiotherapy / Chairman SONCOS Radboud UMC |
|
![]() Professor of Surgical Oncology LUMC |
![]() * Group Leader Evolutionary Intelligence (CWI) * Professor of Evolutionary Algorithms at Delft University of Technology |
|
![]() Surgical Oncology UMC Utrecht |
|
SAB members cannot be involved in research proposals or be an applicant for a proposal of which they are the judge. Moreover, they cannot in any other way have interests which could result in a conflict of interest. They are dedicated to the ‘Guideline Conflict of Interest SAB’ and should act accordingly. The guideline orders SAB-members to be open about their relationship and interests concerning the applicant and his or her project proposal. In case a conflict of interest is detected (work related, personal of financial) it is not possible to act as a judge.
Members of the board and the SAB are entitled to a non-excessive fee for their activities, according to article 5.3 of het memorandum of association of the Hanarth Fonds. Moreover, they are entitled to a compensation of the costs they have made during the execution of their position (expense allowance).
A balance sheet and a report of income and expenditure of the Hanarth Fonds are delivered by the board annually, within six months after the end of the financial year (calendar year). These serve to show the value development of the assets managed by the Hanarth Fonds during the past year and the value of the assets at the end of that year. These are subject to audit.
Please find the annual report 2022 here (note: Dutch version)
Please find the policy plan 2023 here (note: Dutch version)
Please find the ANBI form 2022 here (note: Dutch version)